CLINICAL AND EXPERIMENTAL IMMUNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2021-11-20 ms1000000807569714

刚投稿就是 under review嘛，直接到ADM那里?

113 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2021-12-29 MS68862005

所有作者在文章接收之后都会接收到邮件吗？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

同一杂志社不同期刊如何转投（transfer）？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2020-02-02 1220f4cbm26(暂无昵称)

同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表:
投了就是Under Review 两周了还没回应稿件编号8000多。。。

spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。

148 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2021-08-20 1471c526m36暂无昵称

想请问一下有没有临床型文章投稿经验啊…

65 0

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2020-12-01 chenwei93

审稿速度:3.0 | 投稿命中率:50.0
经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。#免疫#

183 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2020-05-01 14834dc8m53(暂无昵称)

请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表::
审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表:
已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！

负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！

148 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2020-02-25 spiritak_34827477

20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表:
同8000-_-||请问多久回应的

181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的

133 0

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2019-11-28 zengqingli

这杂志是个坑，二十多天后没送审，效率奇低！！

128 0

[GetPortalCommentsPageByObjectIdResponse(id=1072146, encodeId=b9a010e2146af, content=刚投稿就是 under review嘛，直接到ADM那里?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a85705753, createdName=ms1000000807569714, createdTime=Sat Nov 20 10:39:17 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088831, encodeId=1c8d1088831bd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088832, encodeId=5771108883244, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584135, encodeId=aa72584135be, content=同8000-_-||请问多久回应的spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=spiritak_34827477 2019-10-30 14:19:00 发表: 投了就是Under Review 两周了还没回应稿件编号8000多。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a182303241, createdName=1220f4cbm26(暂无昵称), createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009583, encodeId=b3c11009583b3, content=想请问一下有没有临床型文章投稿经验啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7e45192195, createdName=1471c526m36暂无昵称, createdTime=Fri Aug 20 00:55:53 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903732, encodeId=41a0903e327c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：英国免疫学协会旗下期刊，感觉背靠大树，比较靠谱（美国免疫学协会旗下期刊是ji）。没有版面费，送审两个月，大修三个月，最后接收。感觉编辑很好说话，一旦大修回投以后就很快了。<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43b34788068, createdName=chenwei93, createdTime=Tue Dec 01 02:34:52 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590086, encodeId=323d5900865c, content=请问一下，杂志靠谱吗，前面的评论感觉都不太好的样子…负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！负70℃思考 2020-03-20 00:00:00 发表: 已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, beContent=负70℃思考 2020-03-20 发表:: 审稿时间：约1个月已接收，杂志还是比较快的，2月13号投稿，3月9日小修，3月19日接收。审稿人都很专业，速度不像网上说的那样慢，效率还是可以。我看了实验室投稿记录，最快的第二天就实时拒稿。这个杂志分值稳定，口碑不错，值得推荐！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f9f5276894, createdName=14834dc8m53(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585333, encodeId=2778585333b1, content=20天被拒未送审无理由复制粘贴式的拒信181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, beContent=181hZAr4126(暂无昵称) 2020-02-02 00:00:00 发表: 同8000-_-||请问多久回应的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580638, encodeId=e65c580638a0, content=这杂志是个坑，二十多天后没送审，效率奇低！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9dv9XPuvlt7YSBibgFZWePiaQENtdUxRCiajVrLxmQrcbKSlHAUZGTTh1anAp88PvHibzribWegNw0dD9ClOEbwFxKw/132, createdBy=eded2509226, createdName=zengqingli, createdTime=Thu Nov 28 21:04:00 CST 2019, time=2019-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579076, encodeId=55295e907635, content=投了就是Under Review 两周了还没回应稿件编号8000多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/05c70c080d84f6afec99dab1d7b5ec27.jpg, createdBy=3a8e5197884, createdName=spiritak_34827477, createdTime=Wed Oct 30 14:19:00 CST 2019, time=2019-10-30, status=1, ipAttribution=)]

2019-10-30 spiritak_34827477

投了就是Under Review 两周了还没回应稿件编号8000多。。。

136 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务